LOYOLA UNIVERSITY OF CHICAGO

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 12243
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
  
 
C07K PEPTIDES 2134
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0066,030 MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASEOct 24, 17Mar 08, 18[A61K, A01K, C07K]
2018/0046,763 Detection and Visualization of Temporal Events in a Large-Scale Patient DatabaseMar 02, 16Feb 15, 18[G06F]
2017/0304,281 METHODS OF USING POTASSIUM CHANNEL INHIBITORS (BLOCKERS) FOR FLUID RESUSCITATIONApr 19, 17Oct 26, 17[A61K]
2016/0264,570 METHOD OF BLOCKING TRANSMISSION OF MALARIAL PARASITENov 14, 14Sep 15, 16[A61K, C07D]
2015/0204,847 HIGH-THROUGHPUT, HIGH-PRECISION METHODS FOR DETECTING PROTEIN STRUCTURAL CHANGES IN LIVING CELLSJan 16, 15Jul 23, 15[G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9675446 Prosthetic implant for medialization thyroplastyMar 04, 14Jun 13, 17[A61F, A61M]
9326955 Combination pharmaceuticals and methods thereof using proteinacious channels as treatments for medical conditionsFeb 07, 14May 03, 16[A61K, G01N]
9029139 Omentum as a source of stromal/stem cells and medical treatment using stromal/stem cellsMar 24, 10May 12, 15[A61K, A01N, C12N]
8785466 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefromOct 30, 09Jul 22, 14[A61K]
8703712 Targeting cancer stem cells with DR5 agonistsMar 18, 11Apr 22, 14[A61K, C12N, A61P, C07K]
8691188 Methods of utilizing the arrestin-2/STAM-1 complex as a therapeutic targetMay 25, 11Apr 08, 14[A61K, C07H, C12Q, C12P]
8686017 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefromJun 14, 10Apr 01, 14[A61K]
8673983 Melanins synthesized chemically or via enzyme catalysisDec 22, 08Mar 18, 14[A01N]
8515779 Systems and methods for national registry data collection as patient care is conductedJun 27, 12Aug 20, 13[G06Q]
8173803 Supramolecular scaffolds and methods of making the sameAug 14, 09May 08, 12[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0174,566 METHODS, FORMULATIONS, AND KITS FOR BACTERIAL DEGRADATIONAbandonedJul 09, 14Jun 23, 16[A01N]
2014/0341,935 MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASEAbandonedAug 30, 12Nov 20, 14[C07K]
2014/0243,579 DUAL-ENERGY IMAGE SUPPRESSION METHODAbandonedFeb 27, 14Aug 28, 14[G06T, A61B, A61N]
2013/0332,198 Systems and Methods for National Registry Data Collection as Patient Care is ConductedAbandonedAug 19, 13Dec 12, 13[G06Q]
2013/0231,262 ENGINEERED PROTEIN: "2-COLOR SERCA", AN ION-MOTIVE ATPase FUSED TO CERULEAN AND YELLOW FLUORESCENT PROTEINAbandonedMar 05, 13Sep 05, 13[C12Q, C12N, G01N]
2012/0282,618 METHODS AND ASSAYS FOR RISK PREDICTION, DIAGNOSIS, AND ANALYSIS OF MYOCARDIAL INFARCTION, HEART FAILURE AND REDUCED CARDIAC FUNCTIONAbandonedMay 04, 12Nov 08, 12[C12Q, G01N]
8129144 Papilloma pseudovirus and preparationExpiredApr 09, 07Mar 06, 12[C12P]
2011/0039,314 Composition for Catalytic Amide Production and Uses ThereofAbandonedAug 13, 10Feb 17, 11[C12P, C12N]
2011/0015,376 Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their ProductionAbandonedAug 25, 08Jan 20, 11[C07K]
7754430 Papilloma virus capsomere vaccine formulations and methods of useExpiredApr 17, 08Jul 13, 10[C12Q]
2010/0167,399 METHOD OF GENERATING REGULATORY T CELLS USING CORD BLOOD AND ADULT BLOOD CD14+ MONOCYTE CELLSAbandonedDec 22, 09Jul 01, 10[C12N]
7632973 Methods for preparing aldehydes by self-aldol condensationExpiredApr 24, 08Dec 15, 09[C07C]
2008/0220,416 Compositions for Inhibiting Cell Growth and Inducing Apoptosis in Cancer Cells and Methods of Use ThereofAbandonedMay 20, 05Sep 11, 08[C12Q]
7416732 Papilloma virus-like particles, fusion proteins as well as processes for their productionExpiredFeb 21, 06Aug 26, 08[A61K]
7371391 Papilloma virus capsomere vaccine formulations and methods of useExpiredFeb 21, 06May 13, 08[A61K]
7205126 Papilloma pseudovirus and preparationExpiredFeb 17, 05Apr 17, 07[C12P]
2007/0055,076 Processes for synthesizing esters by 1,4-addition of alkanoic acids to myrcene or isopreneAbandonedJul 08, 04Mar 08, 07[C07C]
2006/0035,889 Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonistsAbandonedAug 15, 05Feb 16, 06[A61K]
2005/0234,257 Facile synthesis of symmetric esters of alkylenebisphosphonic acidsAbandonedMay 25, 05Oct 20, 05[C07F]
6909010 Facile synthesis of symmetric esters of alkylenebisphosphonic acidsExpiredApr 05, 02Jun 21, 05[C07F]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.